IDT Australia Limited (ASX:IDT)
Australia · Delayed Price · Currency is AUD 0.0490
-0.0020 (-3.92%)
Jan 30, 2026, 12:11 PM AEST
IDT Australia Company Description
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States.
The company offers microbiological and analytical testing, clinical packaging, and pharmacy services.
It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms.
In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services.
IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
IDT Australia Limited
| Country | Australia |
| Founded | 1975 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Paul McDonald |
Contact Details
Address: 45 Wadhurst Drive Boronia, VIC 3155 Australia | |
| Phone | 61 3 9801 8888 |
| Website | en.idtaus.com.au |
Stock Details
| Ticker Symbol | IDT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000IDT0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jim Sosic | Chief Operating Officer |
| Paula Coutts | Director of People and Safety |
| Michael B. Thompson | Director of Commercial and Business Development |
| Robert Caunce | Director of Quality |
| Malika Perera | Head of Finance |
| Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Company Secretary |